Case Study Of Patients With COVID-19

The COVID-19 outbreak quickly became a pandemic. In Brazil, more than seven million cases were recorded in 2020. Most patients affected by the disease were admitted to intensive care units (ICU), requiring qualitative polypharmacy, increasing the risk of serious adverse drug reactions (ADE), especially cardiovascular. The COVID-19 medical emergency has highlighted the need for rapid action in the medication management of ICU patients. Thus, the use of technologies to assist the work of healthcare professionals can be decisive in patient survival, especially in ICU overcrowding scenarios. This study aimed to identify cardiovascular ADE in the ICU of a reference hospital for the treatment of COVID-19 in Brasília, Brazil.